AdipoPhYt’s founding principle since its creation in 2010 is that adipose tissue biology is central to weight management and metabolic diseases. Using specific know-how and proprietary technology, AdipoPhYt has developed a range of ex vivo adipose tissue products & services in order to improve clinical decision making and translational medicine.
The Company's business is concentrated on ex vivo based assays for use in drug discovery, nutrition and cosmetic research. Discovery programs are conducted either in partnership or by AdipoPhYt R&D.
AdipoPhYt Company staff, recruited from both industrial science and academic research, forms an experienced team, equally familiar with quality assurance, project milestones and customer support as with research and technological innovation.
Company Details
- Founded
- -
- Address
- 91 Bd De L’ Hôpital, Paris,idf 75013,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://adipophyt.com
- Keywords
- Adipocyte, obesité, perte de poids, diabète, nutrition, microbiote, cardio-vasculaire, minceur, maigrir.
- HQ
- Paris, Idf
Adipophyt Questions
Adipophyt's website is http://adipophyt.com
Adipophyt's LinkedIn profile is https://fr.linkedin.com/company/adipophyt-1
Adipophyt's industry is
Biotechnology Research
Adipophyt's top competitors are
Coave Therapeutics,
Nūmi®,
Alphaonco,
Spikimm,
Nanobacterie,
Karcinolys,
Brainvectis,
Mitologics,
Ennodc,
Altevax Biotech.
Adipophyt's categories are Biotechnology Research
Adipophyt's founding year is 2010
